Tacrolimus

FDA NDC Directory

Ingredient names as written by FDA

TACROLIMUS, TACROLIMUS ANHYDROUS

Dosage forms

Capsule, Capsule, Coated, Extended Release, Capsule, Extended Release, Capsule, Gelatin Coated, Granule, For Suspension, Injection, Injection, Solution, Ointment, Tablet, Extended Release

Routes

Intravenous, Oral, Topical

Manufacturers / labelers

36

Strengths listed

.2 mg/1 · .3 mg/g · .5 mg/1 · .75 mg/1 · 1 mg/1 · 1 mg/g · 4 mg/1 · 5 mg/1 · 5 mg/ml

Brand names in FDA listings

Astagraf Xl, Envarsus Xr, Prograf, Tacrolimus

RxNorm (National Library of Medicine)

Ingredient concept RxCUI 42316

Drugs@FDA applications

Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.

Official labeling on DailyMed

• TACROLIMUS CAPSULE [MAJOR PHARMACEUTICALS] · version 5 · 2026-07-28
• TACROLIMUS CAPSULE [STELLON BIOTECH INC.] · version 3 · 2026-07-20
• TACROLIMUS CAPSULE [A-S MEDICATION SOLUTIONS] · version 5 · 2026-06-23
• TACROLIMUS CAPSULE [NORTHSTAR RX LLC] · version 4 · 2026-06-08
• TACROLIMUS CAPSULE [MAJOR PHARMACEUTICALS] · version 7 · 2026-06-08
• TACROLIMUS (TACROLIMUS) CAPSULE [BIOCON PHARMA INC.] · version 12 · 2026-05-26
• TACROLIMUS CAPSULE [STRIDES PHARMA SCIENCE LIMITED] · version 19 · 2026-05-25
• TACROLIMUS OINTMENT [GLENMARK PHARMACEUTICALS INC., USA] · version 8 · 2026-04-16
• TACROLIMUS CAPSULE [SAFECOR HEALTH LLC] · version 3 · 2026-04-09
• TACROLIMUS CAPSULE, EXTENDED RELEASE [AMNEAL PHARMACEUTICALS NY LLC] · version 1 · 2026-03-25
• TACROLIMUS CAPSULE, GELATIN COATED [JUBILANT CADISTA PHARMACEUTICALS INC.] · version 2 · 2026-03-23
• TACROLIMUS OINTMENT [E. FOUGERA & CO. A DIVISION OF FOUGERA PHARMACEUTICALS, LLC] · version 13 · 2026-02-27

Showing the 12 most recent of 45 labels.